Nasdaq · CIK 0001782223
PYXS Pyxis Oncology, Inc.
Insider trading from SEC Form 4. Last filing 2 d ago.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
4
with a Form 4 at this company
Signals
Open-market buys and sells at Pyxis Oncology, Inc., scored.
| Score | Side | Insider | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 36Weak | buy | Connealy Pamela Ann CFO & COO | $174k | 88,850 | +8% | - |
Transactions
The last 6 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | GordonMD Global Investments LP owner | POpen-market purchase Common Stock Purchase Warrantderivativeindirect: See footnote | +7,172,000 | - | - | 7,172,000 | 2 d ago |
| Dec 23, 2024 | Connealy Pamela Ann CFO & COO | AGrant or award Stock Option (Right to Buy)derivative | +310,000 | $0.00 | $0 | 310,000 | Dec 23, 2024 |
| Dec 23, 2024 | Wadhane Jitendra SVP, Chief Accounting Officer | AGrant or award Stock Option (Right to Buy)derivative | +150,000 | $0.00 | $0 | 150,000 | Dec 23, 2024 |
| Dec 23, 2024 | Sullivan Lara Chief Executive Officer | AGrant or award Stock Option (Right to Buy)derivative | +1,135,000 | $0.00 | $0 | 1,135,000 | Dec 23, 2024 |
| Nov 26, 2024 | Connealy Pamela Ann CFO & COO | POpen-market purchase Common Stockindirect: By Trust | +5,450 | $2.00 | $11k | 1,115,743 | Nov 27, 2024 |
| Nov 26, 2024 | Connealy Pamela Ann CFO & COO | POpen-market purchase Common Stockindirect: By Spouse | +83,400 | $1.96 | $163k | 1,199,143 | Nov 27, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Connealy Pamela AnnCFO & COO
- GordonMD Global Investments LPowner
- Sullivan LaraChief Executive Officer
- Wadhane JitendraSVP, Chief Accounting Officer
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.